Publication | Open Access

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Neuro-oncologyProgression-free SurvivalPancreatic CancerMedicinePhase IiiPharmacologyPathologyFinal Overall SurvivalNeuroendocrine TumorsOncologyRadiation OncologyMolecular OncologyEndocrine-related Cancer